Clinical trial NCT05111938: Friends, Family & Food: Food Allergy App for Youth - II
Official title: Friends, Family and Food: Interactive Virtual Environments for Children With Food Allergies - II
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Food Allergy in Children
Keywords: food allergy
intervention
virtual
pediatric
Lead sponsor: Rhode Island Hospital
Sponsor class: OTHER
Collaborators: name: Virtually Better, Inc.
First posted: 2021-11-08
Enrollment: 80
Sex: ALL
Minimum age (years): 8
Maximum age (years): 12
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: AB/BA crossover: participants were randomized to Arm A (Standard Care (SC) then F3A-App), or Arm B (F3A-App then SC)
Primary purpose: OTHER

Brief summary: Objective: This Phase II STTR grant incorporated user feedback collected in an earlier development project to build interactive, web-based software that helps children with food allergies learn about their condition and gain self-management skills. This highly interactive game allows children to progress through virtual scenes to help them learn about food avoidance, symptom detection, and reaction management. In addition, this project built gaming complexity, with more levels and game options, of the two interactive games "Label Learning: Like it or Lose it!" and "Reaction Action!." Research Procedures: The researchers elicited input from 8 families of children (ages 8-12) with food allergies and their parents by presenting some of preliminary intervention materials (e.g., storyboards of a child in a family gathering involving food) in a focus group format. After that, up to 40 families of children with food allergies (ages 8-12) were recruited to participate in an "open trial". Families were asked to use the software for two weeks and provide feedback on the software. Up to 100 families of children with food allergies (ages 8-12) were then recruited to participate in a Randomized Clinical Trial (RCT) to assess the efficacy of the F3A-App vs. Standard Care (brief office visit and educational handouts). Families in the clinical trial were asked to use the software for two weeks and complete a standard care allergy office visit. This design enabled the investigators to evaluate combined effects of Standard Care and the F3A-App through typical treatment channels (e.g., is the greatest efficacy found after a physician refers family to use the App after an office visit?). Gains in families' knowledge and confidence in food allergy management were evaluated, and interviews with families were conducted to gain further input regarding the software's credibility, usability, and acceptability.

This entry describes only the RCT portion of this Phase II STTR project.

Detailed description: The central goal of this project was to develop an interactive, game-based application (App) for school-aged children (aged 8-12) with food allergies (FA) that would increase knowledge, improve behavioral skills for disease management, and ultimately reduce risk of negative outcomes. An effective FA intervention for children should target content areas of food avoidance and reaction management, and across these areas facilitate knowledge acquisition, develop behavioral skills, and provide practice using these skills in social contexts. The "Friends, Family, and Food App (F3A-App)", consists of four related parts: (a) an interactive, game-based application that is the core of the program, (b) the experiential scenarios in interactive environments (e.g., school cafeteria vignette) that target knowledge and behavioral skills practice in social contexts, (c) two engaging multi-level games to build skills in food avoidance (Label Learning: Like it or Lose it!) and symptom assessment (Reaction Action!), and (d) a multi-tiered reward system that uses token economy-based reinforcement to enhance motivation and engagement (SeaLife Spectacular). From a user perspective, the interactive, game-based application provides opportunities to practice behavioral skills (e.g. negotiating pressures to accept trigger foods, requesting assistance from adults, responding to teasing/bullying) in role-play situations with immediate feedback and reinforcement.

In this Phase II project, the investigators proposed to produce a fully-developed version of the F3A-App, including added content and enhanced features, and evaluate the final product in a randomized clinical trial.

The specific aims of Phase II were:

1. To refine the F3A-App based on the user feedback and data collected in Phase I.
2. To develop and field test additional content, including two additional interactive environments (family gathering, school pot-luck); and to increase gaming complexity (i.e., more levels and options) in Label Learning: Like it or Lose it! and Reaction Action! A small open trial was conducted, in which 40 children with FA, ages 8-12, used selected segments containing the newly developed content. Children used the application for 2 weeks on their home computer or tablet. Feedback about device preference and usage was used to determine the focus of the Evaluation Stage (Aim 3).
3. To assess the efficacy of the F3A-App vs. Standard Care (brief office visit and educational handouts) in a randomized clinical trial with 100 children with FA, ages 8-12. The investigators expected the F3A-App would improve children's FA knowledge and self-efficacy to manage FA (primary outcomes) and would increase parent-child communication regarding FA management relative to Standard Care (secondary outcome). The study's crossover design also made it possible to evaluate combined effects of Standard Care and the F3A-App through typical treatment channels (e.g., is the greatest efficacy found after a physician refers family to use the App after an office visit?) This Phase II STTR targeted pediatric FA, a critical public health problem of increasing prevalence. The approach was innovative by incorporating an emphasis on behavioral skills practice using a platform that is engaging, interactive, affordable, and has high potential for broad dissemination. The researchers envision that the F3A-App will ultimately serve as a template for interactive, game-based applications for children with other chronic conditions requiring self-management, such as asthma, diabetes, and celiac disease.

This entry describes only the RCT portion of this Phase II STTR project.

Eligibility criteria: Inclusion Criteria:

1. child must be 8-12
2. child must have an active diagnosis of FA, confirmed by a physician
3. child and parent must speak and read English
4. child must have access to a computer with internet access
5. child must have access to a smartphone or table

Exclusion Criteria:

any chronic health condition requiring substantial dietary self-management (e.g., diabetes)

Primary outcomes:
measure: Change in Food Allergy Management Assessment Scale (FAMAS) scores
timeFrame: Change in various elements of FA management (pre/post F3A-App use or Standard Care office visit, depending on randomized group assignment)
measure: Change in scores on the Food Allergy Independent Measure (FAIM)
timeFrame: Change in FA-related anxiety (pre/post F3A-App use or Standard Care office visit, depending on randomized group assignment)
measure: Change in scores on the Food Allergy Self-Efficacy
timeFrame: Change in self-efficacy related to self-tx of FA (pre/post F3A-App use or Standard Care office visit, depending on randomized group assignment)
measure: Change in Food Allergy Knowledge scores
timeFrame: Change in FA-related knowledge (pre/post F3A-App use or Standard Care office visit, depending on randomized group assignment)
measure: Change in Parent-Child Communication related to Food Allergy
timeFrame: Change in amount of parent-child discussion related to FA (pre/post F3A-App use or Standard Care office visit, depending on randomized group assignment)
Secondary outcomes:
Other outcomes:
measure: Acceptability of the Friends, Family and Food App (F3-App): Technology Post-Trial Impressions Questionnaire
timeFrame: Follow up (after use of the F3-App; approximately 8 week after baseline)
measure: Credibility of the F3-App: Technology Post-Trial Impressions Questionnaire
timeFrame: Follow up (after use of the F3-App; approximately 8 week after baseline)
measure: Adherence to the use of the F3-App during study
timeFrame: Follow up (after use of the F3-App; approximately 8 week after baseline)
measure: Food Allergy Caregiver-Child Communication
timeFrame: Baseline and Follow up (after use of the F3-App; approximately 8 week after baseline)
Locations:
Study officials:
affiliation: Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
name: Kathy Mann-Koepke, PhD
role: STUDY_CHAIR
References: